• Shuffle
    Toggle On
    Toggle Off
  • Alphabetize
    Toggle On
    Toggle Off
  • Front First
    Toggle On
    Toggle Off
  • Both Sides
    Toggle On
    Toggle Off
  • Read
    Toggle On
    Toggle Off
Reading...
Front

Card Range To Study

through

image

Play button

image

Play button

image

Progress

1/36

Click to flip

Use LEFT and RIGHT arrow keys to navigate between flashcards;

Use UP and DOWN arrow keys to flip the card;

H to show hint;

A reads text to speech;

36 Cards in this Set

  • Front
  • Back
Insulin lispro
short acting insulin and used to cover meal carbs
Regular Humulin R
short acting insulin and used to cover meal carbs
Humulin NPH
longer acting insulin that is used to cover more basal level of insulin
Insulin Glargine
longer acting insulin that is used to cover more basal level of insulin
Metformin
is a Biguanide drug; exact mechanism unknown but we know that it decreases insulin resistance (ineffective in the absence of insulin)
Metformin adverse effects
diarrhea, nausea, anorexia; metallic taste, lactic acidosis (rare)
Metformin contraindications
renal disease, hepatic disease or alcohol abuse, history of lactic acidosis, decreased tissue perfusion or hemodynamic instability
Pioglitazone
Thiazolidinedione; more GLUT 4, more glucose going out of blood and into the cell
Rosiglitazone
Thiazolidinedione; more GLUT 4, more glucose going out of blood and into the cell
PPAR gamma with Thiazolidinediones
peroxisome proliferator-activated receptor-gamma; this increases gene transcription (intracellular receptor); more GLUT 4, more glucose going out of blood and into the cell
Adverse effects of the Thiazolidinediones
fluid retention (contraindicated in NYHA Class III and IV heart failure), WEIGHT GAIN, and increased fracture risk (in women only); also anemia and hepatotoxicity; Rosiglitazone: data suggesting an increased risk of cardiovascular events, such as myocardial infarction and stroke (restricted use)
Glimepiride
Sulfonylurea drug
Glipizide
Sulfonylurea drug
Glyburide
Sulfonylurea drug
Sulfonylurea drug
work by binding to the K channel on pancreatic beta cells thus depolarizing the cell stimulating the voltage-gated calcium channels, increasing calcium thus stimulating insulin secretion (increase the amount of insulin secreted with each pulse, doesn’t increase frequency of pulses)(no effect on basal insulin secretion)
Adverse effects of Sulfonylurea drugs
hypoglycemia, weight gain, nausea, vomiting, allergic skin reactions, cholestatic jaundice, leucopenia, thrombocytopenia, hemolytic anemia, hyponatremia and the syndrome of inappropriate secretion of antidiuretic hormone (SIADH)
Repaglinide
Meglitinide Drug
Nateglinide
Meglitinide Drug
Meglitinide Drugs
binds to a different site on the K channel than the sulfonylurea; inhibits the ATP-sensitive K channels in the same manner as the sulfonylureas
Exenatide
GLP-1 agonists aka Incretin mimetics
Liraglutide
GLP-1 agonists aka Incretin mimetics
Adverse effects of GLP-1 agonists aka Incretin mimetics
hypoglycemia, pruritus, uticaria, rash, and acute pancreatitis
-with Liraglutide have risk of thyroid cancer
Sitagliptin
DPP-IV inhibitors
Saxagliptin
DPP-IV inhibitors
Pramlintide
Amylin mimetic; probably want to decrease insulin dose when adding because it could cause hypoglycemia
Acarbose
Alpha-Glucosidase inhibitors
Miglitol
Alpha-Glucosidase inhibitors
Lutropin
recombinant human LH
Follitropin
recombinant human FSH
Choriogonadotropin
recombinant human hCG
Gonadorelin
(natural GnRH) - no longer used for induction of ovulation; sometimes used diagnostically
Leuprolide
long acting GnRH analogs
Nafareline
long acting GnRH analogs
Ganirelix
GnRH antagonist; Used to inhibit premature LH surges prior to harvesting eggs for in vitro fertilization
Abarelix
GnRH receptor antagonist; used to treat advanced prostate cancer
-danger of life-threatening allergic reactions in 4% of patients
Degarelix:
GnRH receptor antagonist; used to treat advanced prostate cancer
-danger of life-threatening allergic reactions in 4% of patients